InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Fleshner Neil e., Directeur Médical. Officer active across 1 company, notably POINT Biopharma Global Inc.. In total, 4 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €4m. History available since 25 May 2022. The latest transaction was disclosed on 31 October 2023 (Don). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Fleshner Neil E. is the Chief Medical Officer at POINT Biopharma Global Inc. In this role, he is responsible for the medical strategy and research initiatives of the company. His expertise in the medical field allows him to lead innovative projects aimed at improving treatments for patients. He plays a key role in the development of new therapies.